Closing the Immunity Gap: How “The Big Catch-Up” is Protecting a Generation of Children

In the wake of the COVID-19 pandemic, the global health landscape faced a silent but devastating crisis: a massive decline in routine childhood vaccinations. This disruption didn’t just stall progress; it created a dangerous “immunity gap” that has allowed preventable diseases like measles to surge across continents. However, a historic multi-year effort known as The Big Catch-Up (BCU) is working to reverse this trend, aiming to rescue millions of children from the brink of preventable illness.

Launched during World Immunization Week, The Big Catch-Up represents one of the largest international coordinated efforts to date. By targeting the most vulnerable populations, the initiative is not just providing shots; it’s rebuilding the very foundation of global health security.

The Scale of the Crisis: Why We Needed a “Catch-Up”

For years, immunization programs were the backbone of child survival. But the pandemic caused unprecedented disruptions. Health systems were stretched thin, lockdowns prevented routine clinic visits, and supply chains faltered. The result was a spike in “zero-dose” children—infants who have not received even a single dose of life-saving vaccines.

The consequences of these gaps are already visible. In 2024, measles cases surged globally, with an estimated 11 million cases reported. The number of countries facing large-scale outbreaks has nearly tripled since 2021. This resurgence is a direct consequence of declining vaccine coverage and the growing number of children falling through the cracks of traditional healthcare systems.

Measuring the Impact: 100 Million Doses and Counting

The Big Catch-Up initiative, a collaborative powerhouse involving Gavi, the Vaccine Alliance, the World Health Organization (WHO), and UNICEF, has already demonstrated that massive scale is possible when global partners align.

Recent data highlights the profound impact of the program across 36 participating countries in Africa and Asia:

• Total Reach: An estimated 18.3 million children aged 1 to 5 have been reached.
• Doses Delivered: More than 100 million doses of life-saving vaccines have been administered.
• Zero-Dose Success: Approximately 12.3 million children who had previously received zero vaccines were finally reached.
• Measles Protection: 15 million children who had never received a measles vaccine are now protected.
• Polio Eradication: The initiative delivered 23 million doses of the inactivated polio vaccine (IPV), a critical step in the global fight to eradicate polio.

The initiative is currently on track to meet its ambitious target of reaching at least 21 million un- and under-immunized children by its scheduled conclusion in March 2026.

“The Big Catch-Up shows what is possible when governments, partners, and communities work together to protect the most vulnerable in society,” said Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance.

Addressing the “Zero-Dose” Challenge and Vaccine Equity

One of the most significant shifts in the BCU strategy is its focus on vaccine equity. Historically, immunization efforts focused heavily on infants under the age of one. However, the pandemic left a massive cohort of “older” children (ages 1 to 5) vulnerable because they missed their routine childhood schedules.

The BCU has systematically leveraged routine immunization systems to identify and vaccinate this older group. By updating age-eligibility policies and training health workers to screen for missed doses during every medical encounter, the program is moving beyond simple one-off campaigns toward systemic change.

In countries like Ethiopia and Nigeria, the results have been transformative. Ethiopia successfully reached over 2.5 million previously zero-dose children, while Nigeria administered millions of doses of IPV alongside other essential vaccines, effectively narrowing the equity gap in underserved communities.

Beyond the Catch-Up: The Necessity of Routine Immunization

While large-scale catch-up campaigns are vital for closing existing gaps, medical experts emphasize that they are not a permanent solution. Catch-up efforts are resource-intensive and should serve as a temporary bridge to restore stability.

The most sustainable way to protect children is through strengthened routine immunization programs. This means ensuring that every child, regardless of whether they live in a conflict zone, a fragile state, or an underserved urban community, has consistent access to healthcare from birth.

As we look toward the midpoint of the Immunimmunisation Agenda 2030 (IA2030), the goal is clear: we must move from “catching up” to “staying ahead.” This requires long-term domestic investment, political will, and a commitment to building resilient health systems that can withstand future global shocks.

Frequently Asked Questions

What is a “zero-dose” child?

A “zero-dose” child is a term used by global health organizations to describe an infant who has not received any of the basic vaccines recommended by the WHO, such as the diphtheria-tetanus-pertussis (DTP) vaccine. These children are at the highest risk for preventable diseases.

Why did vaccination rates drop during the pandemic?

COVID-19 caused widespread disruptions to healthcare delivery. Many clinics closed, health workers were reassigned to pandemic response, and families faced movement restrictions or fears of visiting medical facilities, leading to a significant backlog in routine childhood immunizations.

Is a catch-up vaccine as effective as a routine vaccine?

Yes. While the timing is not ideal, vaccines are highly effective even when administered later than the recommended schedule. The priority is to ensure the child develops immunity as soon as possible to prevent disease outbreaks.

Forward-Looking Statement: As the global community marks the progress of The Big Catch-Up, the focus shifts to sustainability. The success of this initiative proves that with targeted investment and international cooperation, we can protect the most vulnerable. However, the fight against vaccine-preventable disease is ongoing, requiring constant vigilance and unwavering support for global health infrastructure.